Weaver C. Barksdale & Associates’s Primerica PRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$9K Sell
91
-23
-20% -$2.19K 0.01% 298
2017
Q3
$9K Buy
114
+4
+4% +$312 0.01% 290
2017
Q2
$8K Buy
110
+14
+15% +$1.1K 0.01% 306
2017
Q1
$8K Sell
96
-25
-21% -$1.95K 0.01% 318
2016
Q4
$8K Sell
121
-6
-5% -$381 0.01% 316
2016
Q3
$7K Buy
127
+15
+13% +$829 0.01% 327
2016
Q2
$6K Sell
112
-32
-22% -$1.66K 0.01% 336
2016
Q1
$6K Buy
144
+24
+20% +$1.04K ﹤0.01% 359
2015
Q4
$6K Sell
120
-9
-7% -$440 ﹤0.01% 351
2015
Q3
$6K Sell
129
-12
-9% -$525 ﹤0.01% 348
2015
Q2
$6K Buy
141
+10
+8% +$467 ﹤0.01% 360
2015
Q1
$7K Buy
131
+25
+24% +$1.3K 0.01% 336
2014
Q4
$6K Sell
106
-13
-11% -$663 ﹤0.01% 349
2014
Q3
$6K Sell
119
-5
-4% -$242 ﹤0.01% 339
2014
Q2
$6K Buy
124
+10
+9% +$459 ﹤0.01% 352
2014
Q1
$5K Sell
114
-8
-7% -$356 ﹤0.01% 387
2013
Q4
$5K Hold
122
﹤0.01% 384
2013
Q3
$5K Sell
122
-10
-8% -$396 ﹤0.01% 382
2013
Q2
$5K Buy
+132
New +$4.56K ﹤0.01% 371

Other funds holding PRI

Weaver C. Barksdale & Associates's PRI Position: Q4 2017 in Review

Weaver C. Barksdale & Associates reduced its Primerica (PRI) stake by 20% in Q4 2017, selling an estimated $2.19K and leaving 91 shares worth $9K. The position accounts for 0.01% of the portfolio, ranked #298.

Weaver C. Barksdale & Associates first reported a position in PRI in Q2 2013 and has held it in 19 quarters since. 285 funds tracked by Wall St. Rank hold PRI as of Q4 2017.

  • Weaver C. Barksdale & Associates held 91 shares of Primerica worth $9K as of Q4 2017.
  • Weaver C. Barksdale & Associates sold 23 Primerica shares in Q4 2017, an estimated $2.19K.
  • Primerica made up 0.01% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #298 holding.
  • Weaver C. Barksdale & Associates first reported a position in Primerica in Q2 2013 and has held it in 19 quarters since.
  • 285 funds tracked by Wall St. Rank held Primerica as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.